Biotechnologies news and biotechnologies widget

[NEWS] LONDON, november 19 /PRNewswire-FirstCall/ — NeuroDiscovery Ltd (ASX: NDL), a specialty neuroscience service provider and drug development Company, and Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565), a leading international biopharmaceutical company, today announce that NeuroSolutions is presenting further pivotal pre-clinical efficacy data for NSL-043/SD118. This investigational drug is a potential therapy for neuropathic pain and has successfully completed Phase I clinical studie…

[NEWS] MACCLESFIELD, England, november 19 /PRNewswire-FirstCall/ — Cyprotex are proud to announce the introduction in their facilities of one of the most sensitive ion trap and triple quadrupole instruments in the industry. The QTRAP® 5500 LC-MS/MS offers unparalleled sensitivity and impressive speed by uniting the world's most sensitive triple quadrupole with the world's most sensitive and fastest scanning linear ion trap. It combines exceptional quantitative and qualitative analytical …

Warrington, PA, Nov, 2008 - Polysciences, Inc. is pleased to announce the launch of the HOPE® Fixative Starter Kit. A new convenient kit that contains all the components necessary to provide improved ... [WebWire - Wednesday, november 19, 2008]

On 18 november 2008, the US FDA responded to AstraZeneca's Citizen Petition surrounding the company's concern about the approval of any generic version of PULMICORT RESPULES® (budesonide inhalation su... [WebWire - Wednesday, November 19, 2008]

FRAMINGHAM, MA (MARKET WIRE) Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) is pleased to announce that it has initiated retail sales of IoGen(TM), its dietary supplement for women's breast health, through its web site, www.BuyIoGen.com. IoGen is the first dietary supplement formulated to promote breast health for women. IoGen can be purchased in 2 month (60 tablets) and 4 month (120 tablets) quantities.

[NEWS] NEW ROCHELLE, N.Y., Nov. 19 /PRNewswire/ — Biotech scientists increasingly are applying genomics technologies to toxicology research to better understand the effects of novel drug candidates on a variety of organ systems, reports Genetic Engineering & Biotechnology News (GEN). They are especially interested in figuring out a new compound's mechanism of action and eventually developing a predictive toxicology technique, according to the november 15 issue of GEN. (<a hre…

[NEWS] WOODCLIFF LAKE, N.J., Nov. 19 /PRNewswire-FirstCall/ — Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has entered into a supply and distribution agreement with AstraZeneca in the U.S. to market budesonide inhalation suspension, which is a generic form of AstraZeneca's Pulmicort Respules® indicated for the maintenance treatment of asthma. Par began shipping 0.25 mg/2 ml and 0….

Oregon’s newest signature research center, The Oregon Translational Research and Drug Development Institute, has named M. Patricia Beckmann as its new executive director.

Workers at the Blue Diamond Growers plant in Sacramento on Wednesday are voting whether to join International Longshore and Warehouse Union Local 17, according to union organizer Augustin Ramirez.

[NEWS]     Study did not achieve statistical significance   ISELIN, N.J., Nov. 19/PRNewswire-FirstCall/ — Pharmos Corporation (Nasdaq: PARS) today announced results from its Phase 2a clinical trial of its topical NanoEmulsion (NE) drug delivery technology formulated with 3% Diclofenac Diethanolamine.   The multi-center, randomized, double-…